Liu Tian
Academic / Other · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Upadacitinib for Refractory Takayasu Arteritis Takayasu Arteritis | — | 2024-03-19 |
| Completed | Upadacitinib for Refractory Behcet's Syndrome Behcet Syndrome | Phase 2 | 2024-01-25 |
| Completed | Baricitinib for Refractory Takayasu Arteritis Takayasu Arteritis | Phase 2 | 2023-04-03 |
| Recruiting | Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Eryt Systemic Lupus Erythematosus | Phase 3 | 2023-02-07 |